e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Diagnostic tests and treatment in non cystic fibrosis bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serological test and chest computed tomography findings in patients with
mycobacterium avium-intracellulare
(MAC) lung disease
R. Maekura, S. Kitada, T. Hiraga, Y. Nishiuti, K. Kobayashi (Toyonaka, Osaka, Tokyo, Japan)
Source:
Annual Congress 2007 - Diagnostic tests and treatment in non cystic fibrosis bronchiectasis
Session:
Diagnostic tests and treatment in non cystic fibrosis bronchiectasis
Session type:
Oral Presentation
Number:
3179
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Maekura, S. Kitada, T. Hiraga, Y. Nishiuti, K. Kobayashi (Toyonaka, Osaka, Tokyo, Japan). Serological test and chest computed tomography findings in patients with
mycobacterium avium-intracellulare
(MAC) lung disease. Eur Respir J 2007; 30: Suppl. 51, 3179
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Neutrophil-dominant inflammation is associated with severity in high-resolution computed tomography (HRCT) findings in patients with nontuberculous mycobacterium (NTM) infection
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Serological test and chest computed tomography findings in patients with Mycobacterium avium complex lung disease
Source: Eur Respir J 2007; 29: 1217-1223
Year: 2007
Chest imaging comparison between non-tuberculous and tuberculosis mycobacteria in sputum acid fast bacilli smear-positive patients
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by mycobacterium avium-intracellulare complex (MAC) infection
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003
Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings
Source: Eur Respir J 2008; 32: 147-152
Year: 2008
From detection of nontuberculous mycobacteria (NTM) in pulmonary specimens to pulmonary infections
Source: Eur Respir J 2004; 24: Suppl. 48, 420s
Year: 2004
Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics
Source: Eur Respir J 2006; 28: 1204-1210
Year: 2006
Exposure to mycobacterium tuberculosis during bronchoscopy in patients with unexpected pulmonary tuberculosis
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Treatment of pulmonary NTM infection: can it be done?
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007
Clinical evaluation of a diagnostic method of tuberculosis infection, QuantiFERON TB-2G, for active tuberculosis and nontuberculous mycobacteriosis
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
TB, NTM and bronchiectasis
Source: ERS Skills Course 2016
Year: 2016
Screening non-tuberculous mycobacteria in patients with bronchiectasis
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Nontuberculous mycobacteriosis - from diagnosis to therapy
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005
Non-tuberculous mycobacteria (NTM) in bronchiectasis - a difficult management problem
Source: Eur Respir J 2003; 22: Suppl. 45, 515s
Year: 2003
Utility of high-resolution computed tomography for the rapid diagnosis of sputum smear and PCR-negative pulmonary tuberculosis
Source: International Congress 2016 – A view into a chest and pleural pathology
Year: 2016
Susceptibility to nontuberculous mycobacterial lung disease
Source: Eur Respir J 2008; 31: 1322-1333
Year: 2008
Cases series on nontuberculous mycobacterial (NTM) lung disease and silicosis in Brazil
Source: International Congress 2017 – Case reports and series
Year: 2017
High-resolution computed tomography (HRCT) findings are good predictors of response to treatment in Mycobacterium avium complex (MAC) pulmonary disease
Source: Breathe 2008; 5: 180
Year: 2008
Disseminated nontuberculous infections with Mycobacterium genavense during sarcoidosis
Source: Eur Respir Rev 2009; 18: 299-301
Year: 2009
Clinical relevance of Mycobacterium simiae in pulmonary samples
Source: Eur Respir J 2008; 31: 106-109
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept